BACKGROUND Myocarditis is inflammation of the heart muscle that can follow various viral infections. Why children
A cute myocarditis (AM) is an inflammatory disease of the myocardium.
The estimated annual incidence of myocarditis is 1 per 100,000 children in the United States, corresponding to a prevalence of w1/10,000 (1). The actual incidence of this heterogeneous disease is probably higher because of unrecognized cases.
Myocarditis most typically presents with sudden onset of congestive heart failure or cardiogenic shock. Some patients recover fully and spontaneously or following symptomatic treatment. Others suffer from cardiac sequelae such as dilated cardiomyopathy (DCM) (1), requiring long-term anticongestive therapy or heart transplantation. In some cases, sudden death occurs (1) . Biopsy-proven myocarditis is reported in up to 46% of children with an identified cause of DCM (2) .
Although myocarditis has many causes, most cases apparently result from infection with viruses, including enteroviruses, adenoviruses, and parvoviruses (1) . Infections from such viruses are common, particularly during childhood; it is unclear, therefore, why only a very small proportion of children develop acute viral myocarditis (AVM). Of note, clinical severity is uncorrelated with viral infectious causes, suggesting a human genetic predisposition. Studies in inbred mice have implicated the major histocompatibility complex and other loci in genetic susceptibility to Coxsackie virus-induced myocarditis (3, 4) . Overall, these observations suggest that human genetic variations, rendering the heart more sensitive to common viral infections, may contribute to the progression of myocarditis, at least in some children.
Severe childhood infectious diseases, including viral diseases striking healthy children, can result from single-gene inborn errors of immunity (5, 6) . Some of these immunodeficiencies have tissue-specific phenotypes, which could reflect restricted viral tropism or tissue specificity of the inborn error. Herpes simplex encephalitis (HSE) and severe pulmonary influenza can be due to brain-and lung-intrinsic defects in interferon (IFN) immunity, respectively (6) . Interestingly, heart, brain, and lungs are typically the only organs severely affected in patients with AVM, HSE, and severe influenza, respectively, despite the ability of the causal viruses to replicate in many tissues.
Moreover, inborn errors of adaptive immunity do not predispose to any of these conditions (7) .
Recently, the case of an adult patient with enteroviral AVM carrying a rare, dominant-negative toll-like receptor 3 (TLR3) allele was reported (8) PATIENT RECRUITMENT AND ETHICS. Our subject inclusion criteria were the following: between 1 month and 16 years of age at the onset of cardiac symptoms; presentation with acute onset of chest pain, dyspnea, and/or congestive heart failure; cardiac magnetic resonance (CMR) findings consistent with inflammation; recent history of febrile illness; absence of known family history of or metabolic disorder associated with cardiomyopathy; and histological evidence of inflammatory infiltrates within the myocardium on myocardial biopsy or cardiac explant when available, according to the Dallas classification (14) . CMR criteria used to diagnose myocardial inflammation were modified from the Lake Louise criteria that apply in the adult population but are less sensitive in children, for whom early gadolinium enhancement findings are difficult to quantify (15), including: 1) evidence of regional or global myocardial edema with T2 hyperintensity (T2 ratio: 2;
where T2 ratio ¼ signal intensity myocardium -to-signal intensity skeletal muscle ); 2) evidence of myocardial hyperemia and capillary leakage with early gadolinium enhancement on cine-steady-state free precession and/or T1-weighted images (acquired early after contrast injection) compared with the skeletal muscle; and 3) evidence of myocardial necrosis and fibrosis (visual assessment) with nonischemic regional distribution at late gadolinium enhancement imaging. 
RESULTS
Human iPSC-derived cardiomyocytes are permissive to CVB3 infection (16) . Here, we generated cardiomyocytes from iPSCs and selected the SIRPa þ /CD90 À population, achieving >95% cardiomyocyte purity. We Genomes, taking into account ethnic heterogeneity (p ¼ 2.22E-03) (Central Illustration, Table 2 ). Next, we performed the same analyses of our in-house database of 2,324 exomes from healthy individuals and patients with diseases other than myocarditis. Like the analysis using the 1000 Genomes cohort, we found a statistically significant enrichment of homozygous Acute myocarditis (AM), a rare, life-threatening disease that often results from common viral infections, occurs annually in w1 in every 100,000 children. AM has been associated with the progression of myocardial dysfunction in certain inherited cardiomyopathies. Results of whole-exome sequencing of 42 children with AM (orange)
were compared with those of healthy individuals (gray) from 1000 Genomes database. Although there were no significant (n.s.) differences between the groups with heterozygous rare genetic variants, homozygous damaging mutations were significantly enriched in the AM patients. *p < 8.33E-03. AM ¼ acute myocarditis.
Belkaya et al. Figure 3A) . The PKP2 A840V substitution in P3 was absent from ExAC, and the remainder of these variants were listed only in heterozygous states with very low allele frequencies in that database ( Table 3) . that the consensus splice donor site of intron 4 was used in most of the wild-type splice variants (79.1%), whereas this was rare for the mutant (0.6%) (Online Figure 4B ). This suggested that the c.G150A substitution causes aberrant splicing of TNNI3 messenger ribonucleic acid, consistent with its annotation.
We then conducted an analysis of the impact of all AM-AVM-associated sequence variants (i.e., damaging vs. benign), using the in silico prediction algorithm CADD together with the mutation significance cutoff (MSC) score, which provides a clinically and biologically relevant CADD cutoff value for genes (24, 25) . For Values are n (%).
Abbreviations as in Table 1 .
Belkaya et al. Therefore, the totality of our data pointed away from AM due to inborn errors of cardiomyocyte-intrinsic immunity in most affected individuals. Our previous findings with HSE and severe pulmonary influenza do not apparently apply to AVM (6).
In contrast, we discovered that rare alleles altering STUDY LIMITATIONS. We were not able to document a viral cause in all the AM cases for which mutations of cardiomyopathy genes were found due to a lack of available tissue. However, the patients in our AM cohort had clear evidence of myocardial inflammation (e.g., troponin leakage, CMR findings), and our positive histological findings in those from whom we obtained biopsy samples established the concept. We cannot exclude the possibility that some of the AM cases we studied were unrelated to a viral infection, perhaps attributable solely to the genetic defects.
Another limitation in this study is the sample size for genetic analyses.
CONCLUSIONS
Our data suggest that AM is not primarily caused by inborn errors of TLR3-IFN immunity but appears to be more commonly related to defects in cardiac structural proteins. Until now, AM has been classified as a nonfamilial, acquired disorder, except when observed rarely in certain inherited cardiomyopathies, particularly ARVC; according to the present study, this nosology may need to be revisited. Future work on AM is needed to determine if the myocardium of such patients is more susceptible to viral infections per se, in which case these defects would define novel mechanism of cell-intrinsic immunity operating in the heart, or whether common viral infections merely and indirectly destabilize inherently vulnerable hearts. Belkaya et al.
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